ROBIN SHERRINGTON 4
4 · Xenon Pharmaceuticals Inc. · Filed Jan 2, 2024
Insider Transaction Report
Form 4
ROBIN SHERRINGTON
See Remarks
Transactions
- Other
Common Shares
2023-12-29−8,398→ 8,398 total
Footnotes (1)
- [F1]Shares were transferred to the Reporting Person's former spouse pursuant to the terms of a settlement agreement dated December 29, 2023 entered into in connection with the dissolution of the Reporting Person's marriage. The Reporting Person no longer reports as beneficially owned any securities owned by his former spouse.